(Q45267582)

11 December 2017

Prevention of irinotecan-induced diarrhea by oral sodium bicarbonate and influence on pharmacokinetics (English)

1 reference

11 December 2017

0 references

Takao Tamura

1

1 reference

11 December 2017

Koichi Yasutake

2

1 reference

11 December 2017

Hogara Nishisaki

3

1 reference

11 December 2017

Takatoshi Nakashima

4

1 reference

11 December 2017

Kazutugu Horita

5

1 reference

11 December 2017

Sigeya Hirohata

6

1 reference

11 December 2017

Arata Ishii

7

1 reference

11 December 2017

Kenichi Hamano

8

1 reference

11 December 2017

Nobuo Aoyama

9

1 reference

11 December 2017

Daisuke Shirasaka

10

1 reference

11 December 2017

Takashi Kamigaki

11

1 reference

11 December 2017

Masato Kasuga

12

1 reference

11 December 2017

1 January 2004

1 reference

11 December 2017

1 reference

11 December 2017

67

1 reference

11 December 2017

5-6

1 reference

11 December 2017

327-337

1 reference

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase

11 December 2017

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

21 January 2018

1 reference

Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.

21 January 2018

1 reference

Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective

21 January 2018

1 reference

Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.

21 January 2018

1 reference

Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients

21 January 2018

1 reference

Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity

21 January 2018

1 reference

Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000082915

1 reference

11 December 2017

1 reference